DocumentImmunomodulation by thalidomide and thalidomide analoguestéléversé par
lptscsi- DocumentThalidomide and Celecoxib for severe COVID-19 Pneumoniatéléversé parlptscsi
- DocumentSingle-Dose_Pharmacokinetics_of_Thalidom.pdftéléversé parlptscsi
- DocumentThalidomide combined with low-dose glucocorticoid in the treatment of COVID-19téléversé parlptscsi
- DocumentLepra_reactions.pdftéléversé parlptscsi
- DocumentPhase I Study of an Immunomodulatory Thalidomide Analog, CC-4047, in Relapsed or Refractory Multiple Myelomatéléversé parlptscsi
- DocumentPomalidomide is nonteratogenic in chicken and zebrafish embryos and nonneurotoxic in vitrotéléversé parlptscsi
- DocumentLEPRA_Analog.pdftéléversé parlptscsi
- DocumentLEPRA_Analog.pdftéléversé parlptscsi
- DocumentDesign, Synthesis, and Biological Evaluation of Novel Non-Piperazine Analogues of 1-[2-(Diphenylmethoxy)ethyl]- and 1-[2-[Bis(4-fluorophenyl)methoxy]ethyl]-4-(3-phenylpropyl)piperazines as Dopamine Transporter Inhibitorstéléversé parlptscsi
- DocumentThe unique psychostimulant profile of modafiniltéléversé parlptscsi
- Documentbcsj.56.280téléversé parlptscsi
Académique Documents
Professionnel Documents
Culture Documents
![Design, Synthesis, and Biological Evaluation of Novel Non-Piperazine Analogues of 1-[2-(Diphenylmethoxy)ethyl]- and 1-[2-[Bis(4-fluorophenyl)methoxy]ethyl]-4-(3-phenylpropyl)piperazines as Dopamine Transporter Inhibitors](https://imgv2-2-f.scribdassets.com/img/document/438690750/149x198/6f8edc8b99/1575930292?v=1)
